137 related articles for article (PubMed ID: 17512704)
1. Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.
Petitpretz P; Choné C; Trémolières F;
Int J Antimicrob Agents; 2007 Jul; 30(1):52-9. PubMed ID: 17512704
[TBL] [Abstract][Full Text] [Related]
2. Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Ruiz-González A; Giménez A; Gómez-Arbonés X; Soler-González J; Sánchez V; Falguera M; Porcel JM
Respirology; 2007 Jan; 12(1):117-21. PubMed ID: 17207036
[TBL] [Abstract][Full Text] [Related]
3. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
Weiss LR
Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Notario G; Spiller J; Palmer R; Busman T
Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.
Adelglass J; Jones TM; Ruoff G; Kahn JB; Wiesinger BA; Rielly-Gauvin K; Siu CO
Pharmacotherapy; 1998; 18(6):1255-63. PubMed ID: 9855324
[TBL] [Abstract][Full Text] [Related]
6. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
[TBL] [Abstract][Full Text] [Related]
7. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
Henry DC; Kapral D; Busman TA; Paris MM
Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
[TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
Urueta-Robledo J; Ariza H; Jardim JR; Caballero A; García-Calderón A; Amábile-Cuevas CF; Hernández-Oliva G; Vivar-Orozco R;
Respir Med; 2006 Sep; 100(9):1504-11. PubMed ID: 16504492
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
Paglia M; Peterson J; Fisher AC; Qin Z; Nicholson SC; Kahn JB
Curr Med Res Opin; 2010 Jun; 26(6):1433-41. PubMed ID: 20394471
[TBL] [Abstract][Full Text] [Related]
10. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
11. Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
Lode H; Eller J; Linnhoff A; Ioanas M;
Eur Respir J; 2004 Dec; 24(6):947-53. PubMed ID: 15572537
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease.
Yoon HI; Lee CH; Kim DK; Park GM; Lee SM; Yim JJ; Kim JY; Lee JH; Lee CT; Chung HS; Kim YW; Han SK; Yoo CG
Int J Chron Obstruct Pulmon Dis; 2013; 8():329-34. PubMed ID: 23874094
[TBL] [Abstract][Full Text] [Related]
13. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.
Naber KG; Roscher K; Botto H; Schaefer V
Int J Antimicrob Agents; 2008 Aug; 32(2):145-53. PubMed ID: 18571904
[TBL] [Abstract][Full Text] [Related]
14. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
Conte JE; Golden JA; McIver M; Little E; Zurlinden E
Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
[TBL] [Abstract][Full Text] [Related]
15. A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Nicodemo AC; Robledo JA; Jasovich A; Neto W
Int J Clin Pract; 1998 Mar; 52(2):69-74. PubMed ID: 9624783
[TBL] [Abstract][Full Text] [Related]
16. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media.
Noel GJ; Blumer JL; Pichichero ME; Hedrick JA; Schwartz RH; Balis DA; Melkote R; Bagchi P; Arguedas A
Pediatr Infect Dis J; 2008 Jun; 27(6):483-9. PubMed ID: 18449063
[TBL] [Abstract][Full Text] [Related]
17. Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis.
Zervos MJ; Heyder AM; Leroy B
J Int Med Res; 2003; 31(3):157-69. PubMed ID: 12870368
[TBL] [Abstract][Full Text] [Related]
18. Oral ofloxacin once daily and doxycycline in the treatment of acute exacerbations of chronic bronchitis.
Punakivi L; Keistinen T; Backman R; Lehtipuu AL; Saarelainen P; Vilkka V; Veneskoski T; Ammälä K; Aro A
Scand J Infect Dis Suppl; 1990; 68():41-5. PubMed ID: 2218421
[TBL] [Abstract][Full Text] [Related]
19. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies.
El Moussaoui R; Roede BM; Speelman P; Bresser P; Prins JM; Bossuyt PM
Thorax; 2008 May; 63(5):415-22. PubMed ID: 18234905
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
